| Dr Guruprasad D Naik, MD | |
|
1000 N Oak Ave, Marshfield, WI 54449-5703 | |
| (715) 387-5511 | |
| Not Available |
| Full Name | Dr Guruprasad D Naik |
|---|---|
| Gender | Male |
| Speciality | Interventional Cardiology |
| Experience | 32 Years |
| Location | 1000 N Oak Ave, Marshfield, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508966813 | NPI | - | NPPES |
| 34421800 | Medicaid | WI |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 45969-20 (Wisconsin) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 45969 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Marshfield Medical Center | Marshfield, WI | Hospital |
| Aspirus Riverview Hospital & Clinics Inc | Wisconsin rapids, WI | Hospital |
| Marshfield Medical Center - Eau Claire | Eau claire, WI | Hospital |
| Marshfield Medical Center - Neillsville | Neillsville, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mchs Hospitals Inc | 5698071173 | 1049 |
News Archive
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Oncolytics Biotech Inc. announced today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers," has been published in the online version of the journal Clinical Cancer Research.
Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories Limited, has announced that Ranbaxy has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine Orally Disintegrating Tablets, 10mg. The antihistamine previously made the switch from the prescription to the OTC market.
Using molecules of DNA like an architectural scaffold, Arizona State University scientists, in collaboration with colleagues at the University of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.
The American Association for Cancer Research and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
› Verified 3 days ago
| Entity Name | Marshfield Clinic Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952347981 PECOS PAC ID: 2264345206 Enrollment ID: O20031106000590 |
News Archive
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Oncolytics Biotech Inc. announced today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers," has been published in the online version of the journal Clinical Cancer Research.
Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories Limited, has announced that Ranbaxy has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine Orally Disintegrating Tablets, 10mg. The antihistamine previously made the switch from the prescription to the OTC market.
Using molecules of DNA like an architectural scaffold, Arizona State University scientists, in collaboration with colleagues at the University of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.
The American Association for Cancer Research and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
› Verified 3 days ago
| Entity Name | Mchs Hospitals Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1093221434 PECOS PAC ID: 5698071173 Enrollment ID: O20180208000096 |
News Archive
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Oncolytics Biotech Inc. announced today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers," has been published in the online version of the journal Clinical Cancer Research.
Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories Limited, has announced that Ranbaxy has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine Orally Disintegrating Tablets, 10mg. The antihistamine previously made the switch from the prescription to the OTC market.
Using molecules of DNA like an architectural scaffold, Arizona State University scientists, in collaboration with colleagues at the University of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.
The American Association for Cancer Research and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Guruprasad D Naik, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 387-5511 | Dr Guruprasad D Naik, MD 1000 N Oak Ave, Marshfield, WI 54449-5703 Ph: (715) 387-5511 |
News Archive
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Oncolytics Biotech Inc. announced today that a paper entitled "Two-Stage Phase I Dose-Escalation Study of Intratumoural Reovirus Type 3 Dearing and Palliative Radiotherapy in Patients with Advanced Cancers," has been published in the online version of the journal Clinical Cancer Research.
Ohm Laboratories, a wholly owned subsidiary of Ranbaxy Laboratories Limited, has announced that Ranbaxy has received approval from the U. S. Food and Drug Administration to manufacture and commercialize its Loratadine Orally Disintegrating Tablets, 10mg. The antihistamine previously made the switch from the prescription to the OTC market.
Using molecules of DNA like an architectural scaffold, Arizona State University scientists, in collaboration with colleagues at the University of Michigan, have developed a 3-D artificial enzyme cascade that mimics an important biochemical pathway that could prove important for future biomedical and energy applications.
The American Association for Cancer Research and Bayer HealthCare are pleased to announce a new partnership that will expand AACR's Basic Cancer Research Fellowship Program for 2015.
› Verified 3 days ago
Kenneth E Engelhart, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5704 | |
Michael E Ryan, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-221-7822 | |
James Nash, DO Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 | |
Maria Voronova, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-1713 | |
Matthew C. Keifer, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 Fax: 715-387-5240 | |
Alan K Mckenzie, MD Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5481 | |
Dr. Khushboo Naginbhai Patel, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1000 N Oak Ave, Marshfield, WI 54449 Phone: 715-387-5511 Fax: 715-387-5240 |